Top

Published in:

01-05-2010 | Case Report

A surgically treated case of Lhermitte–Duclos disease with a precise natural history and high uptake of FDG on PET

Authors: Yuko Goto, Naoya Hashimoto, Yoshiko Okita, Tetsu Goto, Carter Rabo, Hiroshi Hirayama, Yoshiharu Horikawa, Manabu Kinoshita, Naoki Kagawa, Toshiki Yoshimine

Published in: Journal of Neuro-Oncology | Issue 3/2010

Abstract

We describe herein a surgically treated case of Lhermitte–Duclos disease in a 33-year-old man. The clinical presentation seemed typical in terms of symptoms, neurological signs, and neuroimaging. High and heterogenous fluorodeoxyglucose uptake in positron emission tomography study is presented and discussed. Furthermore, we performed volumetric analysis of the tumor with sequential magnetic resonance imaging over the course of 7 years before surgery, making this report the first with a long-term natural history, revealing that this rare disease entity may have a neoplastic nature.

Eberhart CG, Wiestler OD, Eng C (2007) Cowden disease and dysplastic gangliocytoma of the cerebellum/Lhermitte–Duclos disease. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. World Health Organization Press, Geneva, pp 226–228

Thomas B, Krishnamoorthy T, Radhakrishnan VV, Kesavadas C (2007) Advanced MR imaging in Lhermitte–Duclos disease: moving closer to pathology and pathophysiology. Neuroradiology 49:733–738CrossRefPubMed

Hashiba T, Hashimoto N, Izumoto S, Kagawa N, Maruno M, Yoshimine T et al (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110:675–684CrossRefPubMed

Lhermitte J, Duclos P (1920) Sur un ganglioneuroma diffus du cortex du cervelet. Bill Assoc Fr Etude Cancer (Fr) 9:99–107

Leech R, Christoferson L, Gilbertson R (1977) Dysplastic gangliocytoma (Lhermitte–Duclos disease) of the cerebellum. J Neurosurg 47:609–612CrossRefPubMed

Prestor B (2006) Dysplastic gangliocytoma of the cerebellum (Lhermitte–Duclos disease). J Clin Neurosci 13:877–881CrossRefPubMed

Meltzer CC, Smirniotopoulos JG, Jones RV (1995) The striated cerebellum: an MR imaging sign in Lhermitte–Duclos disease (Dysplastic gangliocytoma). Radiology 194:699–703PubMed

Klisch J, Juengling F, Spreer J, Koch D, Thiel T, Buchert M et al (2001) Lhermitte–Duclos disease: assessment with MRI imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. Am J Neuroradiol 22:824–830PubMed

Pirotte B, Goldman S, Baleriaux D, Brotchi J (2002) Fluorodeoxyglucose and methionine uptake in Lhermitte–Duclos disease: case report. Neurosurgery 50:404–408CrossRefPubMed

10.

Padma MV, Jacobs M, Sequeira P, Adineh M, Satter M, Kraus G et al (2004) Functional imaging in Lhermitte–Duclos disease. Mol Imaging Biol 6:319–323CrossRefPubMed

11.

Nalagawa T, Maeda M, Kato M, Terada N, Shimizu S, Morooka Y et al (2007) A case of Lhermitte–Duclos disease presenting high FDG uptake on FDG-PET/CT. J Neurooncol 84:185–188CrossRef

12.

Hayasaka K, Nihashi T, Takabayashi S, Bundoh M (2008) FDG PET in Lhermitte–Duclos disease. Clin Nucl Med 33:52–54CrossRefPubMed

13.

Bicik I, Raman R, Knightly JJ, Di Chiro G, Fulham MJ (1995) PET FDG of pleomorphic xanthoastrocytoma. J Nucl Med 36:97–99PubMed

Title: A surgically treated case of Lhermitte–Duclos disease with a precise natural history and high uptake of FDG on PET
Authors: Yuko Goto
Naoya Hashimoto
Yoshiko Okita
Tetsu Goto
Carter Rabo
Hiroshi Hirayama
Yoshiharu Horikawa
Manabu Kinoshita
Naoki Kagawa
Toshiki Yoshimine
Publication date: 01-05-2010
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2010
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-009-0042-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A surgically treated case of Lhermitte–Duclos disease with a precise natural history and high uptake of FDG on PET

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells

Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma

The role of salvage reirradiation for malignant gliomas that progress on bevacizumab

Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade